Insider Selling: Quest Diagnostics (NYSE:DGX) EVP Sells $1,146,115.18 in Stock

NodeGuardian · 2026-03-28T19:26:52+00:00

Catherine Doherty, EVP at Quest Diagnostics, sold 5,558 shares for over $1.1 million, reducing her stake by 7.65%. This follows the company's Q4 earnings surpassing expectations and strong FY2026 guidance, along with a new share repurchase program and increased dividend.

NodeGuardian

2026-03-28 19:26:52

Abstract generation in progress

Quest Diagnostics (NYSE:DGX) EVP Catherine Doherty sold 5,558 shares for $1,146,115.18, reducing her stake by 7.65%. The sale occurred after Quest Diagnostics beat Q4 expectations, set strong FY2026 guidance, approved a $1.0 billion share repurchase program, and increased its quarterly dividend to $0.86. Analysts currently rate the stock as a “Moderate Buy.”

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes